Enoblituzumab, CAS [[1353485-38-7]]

Produktübersicht

• Artikelname: Enoblituzumab, CAS [[1353485-38-7]]
• Artikelnummer: TGM-T9901A-002
• Hersteller Artikelnummer: T9901A-002
• Alternativnummer: TGM-T9901A-002-1MG,TGM-T9901A-002-5MG,TGM-T9901A-002-10MG,TGM-T9901A-002-25MG,TGM-T9901A-002-50MG,TGM-T9901A-002-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: MGA271 , TJ-271

Produktbeschreibung

Enoblituzumab is a humanized IgG1 kappamab monoclonal antibody that recognizes human B7-H3 protein and can be used to study solid tumors such as non-small cell lung cancer (NSCLC).

Produkteigenschaften

• Reinheit: 98.50%
• CAS Nummer: [1353485-38-7]
• Target-Kategorie: Others|||Immunology/Inflammation related|||B7